Leukemia - Hematology Advisor

Leukemia

LEUKEMIA

FEATURE


LATEST ARTICLES


FDA Greenlights New Rituxan Biosimilar

The Food and Drug Administration (FDA) has approved Ruxience (rituximab-pvvr; Pfizer), a biosimilar to Rituxan (Genentech and Biogen), for the treatment of adult patients with non-Hodgkin’s lymphoma, chronic lymphocytic leukemia, and granulomatosis with polyangitis and microscopic polyangiitis. The approval was based on a comprehensive data package which included results from the REFLECTIONS B3281006 study in…
Next post in Leukemia